Activity Dates: 11/04/2021 - 08/03/2022
This activity serves as an educational tool for pharmacists seeking Board Certified Psychiatric Pharmacist (BCPP) Recertification credit and other pharmacists and health care providers seeking advanced education in patient management, disease state management, information management, and health policy and practice management in the field of psychiatric pharmacy.
The CPNP Substance Use Disorder (SUD) Summit 2021 content is intended to improve your ability to care for patients with co-occurring substance use disorder(s) and mental illness. The SUD Summit offers 7.5 hours of ACPE- and BCPP- approved programming focused on the complicated relationships between substance use disorders and mental illness. The goal of the Summit is for participants to leave with knowledge and tools to apply in their practice setting as they provide care to those living with substance use and mental health disorders. After attending this Summit, the participant will be able to:
The curriculum includes:
The 2021 Substance Use Disorder Summit 2021 is an application-based continuing pharmacy education (CPE) activity designed to improve competency of partcipants. An application-based CPE activity requires that participants apply the information learned. In an application-based CPE activity, the learning objectives are written at a higher level in order to assess the learners’ ability to use the information that is learned at the current level of practice by Board Certified Psychiatric Pharmacists. The examination for this product often features case studies requiring that the participant apply the principles learned through the readings
To satisfactorily complete the Summit and receive 7.5 hours of BCPP Recertification and ACPE credit, candidates must meet the following requirements:
You will proceed through the following steps to satisfactorily complete this course:
Participants successfully passing the required assessment/examination will obtain both ACPE and BCPP recertification credit. Credit is awarded in the calendar year the assessment is completed. ACPE credit is reported through CPE Monitor within days of examination submission, while BCPP recertification credit is reported to BPS within 6 weeks after the examination deadline.
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Michelle Geier, PharmD, BCPP, APh
Ericka Crouse, PharmD, BCPP, BCGP, FASHP, FASCP
Sandra Mullen, PharmD, BCPP
Theresa Frey, PharmD, BCPP
Brian Miller, MD, PhD, MPH
James Gasper, PharmD, BCPP
Deirdre A. Conroy, PhD
| Topic |
|
Reducing Stigma While Optimizing Care of the Dually Diagnosed Patient ACPE #: 0284-0000-21-051-H04-P (Application) Speaker: Michelle Geier, PharmD, BCPP, APh Learning Objectives:
|
|
To Treat or Not? Recognizing Symptoms of Withdrawal Versus Acute Psychiatric Symptoms ACPE #: 0284-0000-21-052-H08-P (Application) Speaker: Ericka Crouse, PharmD, BCPP, BCGP, FASHP, FASCP Learning Objectives:
|
|
ADHD with Co-Occurring Stimulant Use Disorder: Focus on the Evidence ACPE #: 0284-0000-21-053-H01-P (Application) Speaker: Sandra Mullen, PharmD, BCPP Learning Objectives:
|
|
Trauma and Alcohol Use Disorder (AUD): Exploring the Complicated Relationship Between PTSD and AUD ACPE #: 0284-0000-21-054-H01-P (Application) Speaker: Theresa Frey, PharmD, BCPP Learning Objectives:
|
|
Cannabis Conundrum – Role of Cannabis Use in Persons with Psychotic Disorders ACPE #: 0284-0000-21-057-H01-P (Application) Speaker: Brian Miller, MD, PhD, MPH Learning Objectives:
|
Finding Light in Darkness: Managing Depression and Anxiety in Persons with OUD ACPE #: 0284-0000-21-056-H01-P (Application) Speaker: James Gasper, PharmD, BCPP Learning Objectives:
|
What’s the Key to Catching Some ZZZ’s? The Complex Relationship between Substance Use Disorders (SUDs) and Sleep Disturbances ACPE #: 0284-0000-21-055-H01-P (Application) Speaker: Deirdre Conroy, PhD Learning Objectives:
|
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Pharmacists can obtain 7.5 hours of ACPE credit and 7.5 hours of BCPP Recertification credit by successfully completing the online examination.
The College of Psychiatric and Neurologic Pharmacists is approved as a Professional Development Provider for the Board Certified Psychiatric Pharmacist (BCPP) specialty by the Board of Pharmacy Specialties (BPS). (Applicable to programs where individual sessions are listed on separate course pages). This course is part of a 7.5 hour BCPP recertification product earned after successful completion of the associated BCPP recertification examination for the full product.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
2021 Planning Committee
|
Ericka Crouse, PharmD, BCPP, BCGP, FASHP, FASCP Co-Chair Associate Professor VCU School of Pharmacy Richmond, VA External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: ASHP - PAM Behavioral Health Committee (volunteer), Editorial Board - The Medical Letter (paid), American Society of Consultant Pharmacists - speak at meetings/webinars on GeroPsych topics (paid), Wolters-Kluwer, paid consultant |
|
Cassandra Davis, PharmD, BCPP, BCPS Mental Health Clinical Pharmacy Specialist Orlando VA Medical Center Orlando, FL No Relevant Financial Relationships to Disclose |
|
Sarah Melton, PharmD, BCPP, BCACP, FASCP Co-Chair Professor of Pharmacy Practice Gatton College of Pharmacy Johnson City, TN Non-Financial Interests: One Care of Southwest Virginia, Virginia Board of Pharmacy |
Troy Moore, PharmD, MS, BCPP |
|
Erika Titus-Lay, PharmD, BCPP, BCPS Assistant Professor California Northstate University College of Pharmacy Elk Grove, CA No Relevant Financial Relationships to Disclose |
All relevant relationships have been mitigated.
This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), or are currently investigational.
In accordance with the Food and Drug Administration (FDA), it is disclosed that there is the potential for discussions concerning off-label uses of a commercial product/devices during this educational activity.
Any person who may contribute to the content of this continuing education activity must disclose significant relationships (and any known relationships of their spouse/partner) with commercial companies whose products or services are discussed in this activity. Significant relationships include receiving from a commercial company research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.
Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.